Considering your experience with Sharlife so far, how likely are you to recommend us to a friend or colleague?
Not at all likelyExtremely likely
(Optional)
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H
874Health technology
$5.7B
Market Cap
Shariah Analysis
Failed
Business
Cash
Liabilities
Based on AAOIFI screening standards, Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H appears to be Failed.
Business Activity
Revenue breakdown data currently unavailable.
Financial Screening
FYE 2024
Cash (<30%)70.87%
Non-Shariah Cash Items
Cash And Cash Equivalents$18.3B
Liabilities (<30%)47.99%
Non-Shariah Liabilities
Long Term Debt$2.8B
Long Term Capital Lease Obligation$445.7M
Current Debt$9.1B
Market Data
Exchange
HKEX
CurrencyUSD
CountryHong Kong
Last Updated2025-12-15
Disclaimer: Shariah screening is based on the latest available financial data. Market conditions and company activities may change. Always conduct your own due diligence.
HKEX
